Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375804 · ClinicalTrials.gov registry record
Racial Disparity in Endometrial Cancer
A clinical trial, sponsored by University of Louisville.
- Terminated
- Registry status
- 43
- Enrollment target
NCT00375804: Clinical Trial study, sponsored by University of Louisville.
NCT00375804 is a clinical trial that was terminated before completion, run by University of Louisville. The registered enrollment target is 43 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00375804 was terminated before completion, sponsored by University of Louisville.
- TERMINATED
- Registry status
- 43 participants
- Enrollment target
Study Summary
The objectives for this study: 1. Investigate some of the causes for the racial disparity of endometrial cancer survival rates among black and white women 2. Examine the biologic correlates of aggressive behavior such as estrogen receptor status, p53 and HER-2/neu overexpression, and aromatase activity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2003-06 |
| Est. Completion | 2010-06 |
Why NCT00375804 stopped before completion
NCT00375804 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 43 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00375804 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00375804 about?
NCT00375804 is a clinical study titled "Racial Disparity in Endometrial Cancer". The objectives for this study: 1. Investigate some of the causes for the racial disparity of endometrial cancer survival rates among black and white women 2. Examine the biologic correlates of aggressive behavior such as estrogen receptor status, p53 and HER-2/neu overexpression, and aromatase acti...
What is the current status of trial NCT00375804?
This trial is currently terminated. The enrollment target is 43 participants. The study started on 2003-06. Estimated completion is 2010-06.
Who is sponsoring clinical trial NCT00375804?
This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia